Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis

Peer Review reports

Original Submission
14 Jan 2021	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
18 Feb 2021	Reviewed	Reviewer Report
21 Feb 2021	Reviewed	Reviewer Report
2 Mar 2021	Author responded	Author comments - Daisuke Watanabe
Resubmission - Version 4
2 Mar 2021	Submitted	Manuscript version 4
31 Mar 2021	Reviewed	Reviewer Report
Resubmission - Version 5
	Submitted	Manuscript version 5
Publishing
8 Apr 2021	Editorially accepted
17 Apr 2021	Article published	10.1186/s12885-021-08177-w

Back to article page